Orbital involvement in craniofacial brown tumors
- PMID: 20305510
- DOI: 10.1097/IOP.0b013e3181b8e3ec
Orbital involvement in craniofacial brown tumors
Abstract
Purpose: To describe the clinical and radiologic features of orbital involvement in craniofacial brown tumors and to compare the rate of brown tumors in primary and secondary hyperparathyroidism.
Methods: A retrospective hospital-based study of 115 patients with chronic kidney disease and secondary hyperparathyroidism and 34 with primary hyperparathyroidism was conducted. Laboratory results such as serum levels of alkaline phosphatase, calcium, phosphorus, and parathyroid hormone were recorded. Demographic data (age, sex, duration of disease) and image findings (bone scan scintigraphy, skull and long bone x-rays, CT) were also obtained. The main outcome measures were analysis of clinical, biochemical, and radiologic findings of all patients.
Results: Of the 115 patients with chronic kidney disease, 10 (8.7%) had brown tumors in different bones of the skeleton. Five patients had lesions in the craniofacial bones. The maxilla, mandible, maxillary sinus, and nasal cavity were the most affected sites. The orbit was involved in 2 patients with lesions arising in the maxillary and ethmoid sinuses. One patient had facial leontiasis. All patients with brown tumors had extremely high levels of parathyroid hormone (>1,000 pg/ml, normal values 10-69 pg/ml) and alkaline phosphatase (>400 U/l, normal values 65-300 U/l). The mean serum levels of phosphorus and calcium were not abnormal among the patients with brown tumors. Age and time of renal failure were similar for patients with and without brown tumors. Among the patients with primary hyperparathyroidism, only 2 (5.8%) had brown tumors, and in just 1, the lesion was localized in the craniofacial skeleton. A 2-tailed Z test applied to compare the proportion of occurrence of brown tumors in the 2 groups revealed that the difference at the 90% of confidence level was not significant.
Conclusions: Brown tumors are equally found in secondary and primary hyperparathyroidism. Craniofacial brown tumors involve the orbit, usually because of the osteodystrophy process that involves the maxilla and paranasal sinuses. The lesions do not necessarily need to be excised and may regress spontaneously after the control of hyperparathyroidism.
Similar articles
-
Highly aggressive brown tumour of the maxilla as first manifestation of primary hyperparathyroidism.Int J Oral Maxillofac Surg. 2000 Dec;29(6):447-9. Int J Oral Maxillofac Surg. 2000. PMID: 11202328
-
Brown tumour involving the orbit: case report and review of the literature.Can J Ophthalmol. 2016 Aug;51(4):e125-e127. doi: 10.1016/j.jcjo.2016.02.020. Epub 2016 Jun 21. Can J Ophthalmol. 2016. PMID: 27521680 Review. No abstract available.
-
Maxillary brown tumor in secondary hyperparathyroidism requiring urgent parathyroidectomy.J Nephrol. 2001 Sep-Oct;14(5):415-9. J Nephrol. 2001. PMID: 11730277
-
[Brown tumors in chronic hemodialysis patients].Nephrol Ther. 2016 Apr;12(2):86-93. doi: 10.1016/j.nephro.2015.09.003. Epub 2016 Feb 19. Nephrol Ther. 2016. PMID: 26907666 French.
-
Brown tumor: clinical findings of secondary hyperparathyroidism in patients with renal osteodystrophy.Gen Dent. 2017 Mar-Apr;65(2):70-74. Gen Dent. 2017. PMID: 28253186 Review.
Cited by
-
Three Rare Concurrent Complications of Tertiary Hyperparathyroidism: Maxillary Brown Tumor, Uremic Leontiasis Ossea, and Hungry Bone Syndrome.J Bone Metab. 2020 Aug;27(3):217-226. doi: 10.11005/jbm.2020.27.3.217. Epub 2020 Aug 31. J Bone Metab. 2020. PMID: 32911586 Free PMC article.
-
Systematic review of oral manifestations related to hyperparathyroidism.Clin Oral Investig. 2018 Jan;22(1):1-27. doi: 10.1007/s00784-017-2124-0. Epub 2017 Jun 14. Clin Oral Investig. 2018. PMID: 28616750
-
Rare brown tumour of the mandible secondary to tertiary hyperparathyroidism in a renal transplant recipient.BMJ Case Rep. 2019 Sep 24;12(9):e231231. doi: 10.1136/bcr-2019-231231. BMJ Case Rep. 2019. PMID: 31551320 Free PMC article.
-
NaF18-PET/CT Imaging of Secondary Hyperparathyroidism.Nucl Med Mol Imaging. 2015 Dec;49(4):331-2. doi: 10.1007/s13139-015-0319-3. Epub 2015 Jan 23. Nucl Med Mol Imaging. 2015. PMID: 26550056 Free PMC article. No abstract available.
-
Maxillary and orbital brown tumor of primary hyperparathyroidism.Am J Case Rep. 2012;13:183-6. doi: 10.12659/AJCR.883325. Epub 2012 Aug 16. Am J Case Rep. 2012. PMID: 23569524 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources